RESEARCH
Circulating Tumor DNA May Guide Adjuvant Chemotherapy After Liver Metastasis SurgeryCirculating tumor DNA for molecular residual disease tracking could help identify patients with colorectal cancer and liver metastases who are most likely to benefit from adjuvant chemotherapy after surgery, according to overall survival findings from the phase II GALAXY study presented at ESMO GI Congress 2026. (The ASCO Post)